Connection

Flora Peyvandi to Surveys and Questionnaires

This is a "connection" page, showing publications Flora Peyvandi has written about Surveys and Questionnaires.
Connection Strength

0.008
  1. Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey. Haemophilia. 2021 Sep; 27(5):736-743.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.